In the latest quarter, 4 analysts provided ratings for RxSight (NASDAQ:RXST), showcasing a mix of bullish and bearish perspectives.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Analysts have set 12-month price targets for RxSight, revealing an average target of $51.5, a high estimate of $72.00, and a low estimate of $40.00. This current average represents a 14.88% decrease from the previous average price target of $60.50.

Investigating Analyst Ratings: An Elaborate Study

The standing of RxSight among financial experts is revealed through an in-depth exploration of...